Antibiotic use in early childhood and the development of asthma

K Wickens1, N Pearce, J Crane

  • 1The Wellington Asthma Research Group, Wellington School of Medicine, Wellington South, Wellington, New Zealand.

Insights

Antibiotic use in early childhood may increase the risk of developing asthma. This study in children attending Rudolf Steiner schools found a significant association between antibiotic exposure and a history of asthma.

Area of Science:

  • Pediatric Allergy and Immunology
  • Infectious Disease Epidemiology
  • Environmental Health

Background:

  • Investigating the link between early-life infections and asthma development.
  • Exploring the potential role of medical interventions, specifically antibiotics, in asthma etiology.
  • Utilizing a unique population (Rudolf Steiner school children) with lower antibiotic usage for comparative study.

Purpose of the Study:

  • To examine the association between antibiotic use in infancy and the subsequent risk of asthma.
  • To evaluate if antibiotic use after infancy also correlates with asthma development.
  • To assess the dose-response relationship between the number of antibiotic courses and asthma risk.

Main Methods:

  • Survey of 456 parents of children aged 5-10 years attending Rudolf Steiner schools in New Zealand.
  • Data collection on antibiotic usage history and child's history of asthma and wheeze.
  • Statistical analysis controlling for potential confounding factors.

Main Results:

  • Antibiotic use was significantly associated with a history of asthma (OR=2.74) and wheeze (OR=1.86).
  • Antibiotic use in the first year of life showed a stronger association with asthma risk (OR=4.05) compared to later use.
  • Increased courses of antibiotics in the first year correlated with higher odds ratios for asthma.

Conclusions:

  • Infant antibiotic exposure may be linked to an elevated risk of developing asthma.
  • Further research is needed to elucidate the mechanisms behind this observed association.
  • The findings suggest a potential impact of antibiotic stewardship on pediatric respiratory health.
Abstract

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...